Christian Ivan Rosero Llerena, MD Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 764 Kennedy St Ste 101, Meadville, PA 16335 Phone: 814-373-2195 Fax: 814-373-2197 |
Dr. Carol Felisa Encarnacion, M.D., M.P.H. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 764 Kennedy St, Suite 101, Meadville, PA 16335 Phone: 814-373-2195 Fax: 814-373-2197 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced data presented for the first time at the 52nd Annual Meeting of the American Society of Hematology showing promising clinical activity, safety and tolerability of perifosine in patients with advanced chronic lymphocytic leukemia (CLL) and Hodgkin's lymphoma (HL). KRX-0401 (perifosine) is the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway.
Roche and the US-based biopharmaceutical company Alnylam Pharmaceuticals, Inc. announced today that they have entered into a major alliance in which Roche obtains a non-exclusive license to Alnylam's technology platform for developing RNAi (RNA interference) therapeutics.
A newly published genome sequence of a breast cancer cell line reveals a heavily rearranged genetic blueprint involving breaks and fusions of genes and a broken DNA repair machinery, said researchers at Baylor College of Medicine in a report that appears online in the journal Genome Research.
A team of scientists led by researchers at Plymouth University Peninsula Schools of Medicine and Dentistry, has received a grant from the Medical Research Council (MRC) for work which could lead to new and effective therapies for those with Parkinson's Disease.
› Verified 5 days ago